Volkswagen lowers sales forecast after weak demand in China
Volkswagen (OTCMKTS:VLKAY) lowered its sales forecast, which expected sales to be flat on last years 10.1 million cars, after weaker demand in China.
This comes after China recorded a 3.4% monthly year-on-year drop in new-car sales in June, its first decline in more than two years. China’s Automakers Association also cut its 2015 forecast for vehicle sales growth to a meager 3 percent last week, as a volatile stock market affected sales to consumers concerned about the slowing economy.
Fluctuations in China’s market will strongly affect VW, where the group’s largest division delivers more than 40 percent of its vehicles.
However, a higher-margin western European market and cost cuts helped VW raise group operating profit to 3.49 billion euros, which does not include earnings from Chinese joint ventures.
“The difficult market environment and fierce competition” is posing challenges, Finance chief Hans Dieter Poetsch said.
VW are currently trading down 2.43% at 40.97 pence per share.
GlaxoSmithKline up 3% after second quarter report
Shares in GlaxoSmithKline (LON:GSK) jumped more than 3 percent this morning after the company reported second-quarter earnings per share (EPS) that were slightly higher than forecast by analysts.
Sales also rose 6 percent to 5.9 billion pounds in the last quarter. They currently have a market capitalization of around £65 billion.
The drugmaker recently sold its marketed cancer drugs to Novartis, and bought the Swiss group’s vaccines. However, the company experienced a slide in sales of the lung drug Advair after an introduction of a generic drug in the US.
Looking long-term, the company currently has several new drugs in the research stage and around 40 new drugs and vaccines in Phase II or Phase III clinical development. They have also just become the first drug company to be given approval from European Medicines Agency for a malaria vaccine.
Chief Executive Andrew Witty is under pressure to deliver recovery after poor profit performance over the past few years.
GlaxoSmithKline plc. (GSK) is a healthcare company that researches and develops pharmaceuticals, vaccines and consumer healthcare products. They are currently trading up 3.16% at 1371 pence per share.
Record demand for Sky pushes profits up
Sky (LON:SKY) have reported an 18 percent jump in full-year operating profit on this morning, slightly above analysts expectations.
Full-year revenue was also up 5 percent to £11.3 billion. Combined with cost cuts across the business, the company reported an operating profit of £1.4 billion.
The positive results were driven by demand for broadband and tv entertainment and success in Europe; Sky, which formed from the combination of Britain’s BSkyB, Sky Deutschland and Sky Italia said the group had seen its highest organic customer growth for 11 years in Britain and Ireland.
Sky have done less well in Italy, where demand has fallen for the past three years. The company reported figures have remained stable, however.
“The investments we have made have given us a strong platform on which to build and we have a clear set of plans to deliver long-term growth and returns for our shareholders,” Chief Executive Jeremy Darroch said.
Sky are currently up 1.07% at 1,135 pence per share.
Barclays reports 25% rise in profits
Barclays bank (LON:BARC) has reported its half-yearly results, led by a 25% rise in pre-tax profits to £3.14bn.
Pre-tax profit was 1.85 billion pounds for the second quarter, up 12 percent from a year ago and ahead of the average analyst forecast of 1.75 billion pounds.
However, the bank have set aside another 850 million pounds to compensate UK customers for mis-sold PPI protection. This will bring the total compensation given up to £6m.
This announcement comes less than a month after the bank’s new chairman John McFarlane sacked Chief Exectutive Antony Jenkins because his turnaround plan for the bank was not working fast enough.
“We need to accelerate the execution of the strategy,” McFarlane said on Wednesday, pinpointing a need to speed up the growth in earnings, return on equity and capital generation.
McFarlane said he plans to cut costs as a percentage of income to “mid 50s” percent, from 68 percent in the first-half of the year. He also plans to cut Barclays’ non-core profits from £57 billion to £45 billion by the end of 2016.
ITV profits rise, despite poor ratings
ITV released their half-yearly earnings this morning, with profits rising by 25% to £391m as revenue increased across all divisions.
Its net advertising revenue for the previous six months was also up 5% to £838m. However, poor ratings led to a decline in viewers for the channel, with its viewing share across all channels falling 4%.
ITV chief executive Adam Crozier said that improving ratings was a “key focus” for the year.
“Our viewing performance was impacted by strong competition from the BBC, no major sporting event and some of our shows not performing as well as we had expected,” the company said.
However, ITV have won exclusive rights to events including the Rugby World Cup and a range of new dramas including Jekyll & Hyde, as well as the return of Downton Abbey in September for its final season. The company seem confident that viewings will pick up next quarter.
Shares in ITV rose 3.5% to 272.9p in morning trading, valuing the company at almost £11bn.
Could Birmingham and Croydon be the next tech hubs?
A few months ago, Birmingham was named the sixth best city for investment in Europe. However, it appears the attraction of the city keeps on growing; its burgeoning tech quarter, or “Silicon Canal” is set to rival London’s Silicon Roundabout.
Greater Birmingham claims to be home to 6,000 technology businesses employing nearly 40,000 people, and is bidding to attract 10,000 new technology jobs by 2020 as the digital boom spreads from London to the regions.
“There’s no reason why Tech City should suck in all the attention and investment from government. If Britain wants to compete in the global tech economy, we must unleash the power of regional cities like Birmingham,” said Neil Rami, chief executive of Marketing Birmingham.
But it’s not just Birmingham that is gearing up to challenge Old Street: a suprising new tech epicentre can also be found in Croydon.
Johnny Rose, founder of Tech City Croydon, disagrees that Birmingham is the new tech city. According to him, “if you want a “community-led initiative”, “incredible talent pool”, and a tech community experiencing “exponential growth”, you don’t need to be travel north, you need to go further south.”
The Office for National Statistics showed that Croydon’s tech startup cluster achieved 23% growth between 2011 and 2013, higher than east London (17.1%) and the UK as a whole (11.3%) averages over this period. Croydon is now home to over a thousand digital, creative and technical startups, including social networks, mobile dining apps, new media outlets and FinTech firms such as QuidCycle.
Whilst many think of Croydon as too suburban to be an industry hub and – possibly – a bit of a dump, they might have been right once; but not any more. Interestingly, Croydon’s Tech City initiative was inspired by its bad reputation and kickstarted by the 2011 riots, which were prominent in Croydon.
Saif Bonar, founder of Matthew’s Yard, a cafe and community hub in Croydon, said:
“Arguably the riots were one of the best things that happened to Croydon”, he says, “Without them, the progress we’ve made would have taken much longer.”
Many new tech firms have seen through Croydon’s grimy exterior, and reaped the benefits. Tech City Croydon organise tech events every week of the year, from advice surgeries to networking events. Gatwick airport is just 15 minutes by train, providing connections to other European start-up centres such as Berlin and Helsinki, and it’s almost easier to get from East or West Croydon via mainline train that across London by tube.
Simon Bird, co-founder of dotMailer: “It is really just an extension of central London, albeit with more cost-effective office and living opportunities. People think it is unsafe, but I really don’t see that and I work here every day.”
As Old Street’s Silicon Roundabout expands and further cements London’s position at the centre of Europe’s Fintech scene, other parts of the country are prospering too. Both Birmingham and Croydon were areas in need of regeneration and fresh talent – and through the growth of tech start-ups, that is exactly what they’ve got. It will now be interesting to see which city will be next to reap the benefits.
Miranda Wadham
Honeywell International to buy arm of Melrose Plc
American company Honeywell International Inc (NASDAQ:HON) has announced that it will buy the utility consumption meter arm of Britain’s Melrose Industries Plc (LON:MRON) for £3.3 billion, in order to boost its presence in high-growth regions.
The deal is for Melrose’s Elster division:
“Elster’s gas business offers products in high demand among natural gas customers and brings a strong, global distribution network and numerous cross-selling opportunities for existing Honeywell technologies,” Honeywell Chief Executive Dave Cote said.
“Elster also creates a new platform for acquisition targets for Honeywell,” Honeywell Chief Executive Dave Cote said.
Melrose shares rose by 16 percent in early trading on Tuesday, making it the top percentage gainer on the FTSE-250 midcap index.
Honeywell International is an American multinational company that produces a variety of commercial and consumer products, engineering services, and aerospace systems for a wide variety of customers.
GKN Aerospace in deal to buy Dutch supplier Fokker Technologies
British engineering company GKN Plc (LON:GKN) have agreed to buy Dutch aerospace supplier Fokker Technologies Group BV for 706 million euros, in order to improve access to growing Asian markets and strengthen their position in the aerospace industry.
GKN Aerospace is one of the world’s largest suppliers of parts for the aviation industry, with 40 bases internationally; the deal will bolster links to the Airbus A350 and Lockheed Martin Corp. F-35 programs.
Nigel Stein, chief executive, said: “Fokker is an excellent strategic and cultural fit which supports our growth strategy. This transaction will increase our shipset value on key growth programmes in both the commercial and military markets.
“Fokker’s sizable China operations also help boost GKN aerospace’s activity in this important region. Fokker is a great business with a strong brand and has significant technology heritage.”
GKN recently reported half-year results that showed group sales edged up 1pc to £3.6bn, while pre-tax profits slipped 5pc to £212m.
The announcement comes just after the company confirmed that 1 in 4 jobs at its Yeovil base will be cut by the end of the year, with the company blaming a drop in the number of orders for the need to reduce its Somerset workforce of 350 staff.
GKN are currently trading up 6.68%.
Hikma Pharmaceuticals announces $2.6 billion deal
Hikma Pharmaceuticals (LON:HIK) are one of the biggest movers on the stock market this morning after announcing an agreement to buy Roxane Laboratories, Inc. and Boehringer Ingelheim Roxane, Inc. from Germany’s Boehringer Ingelheim GmbH.
The deal will attempt to enlarge Hikma’s position in the US market and, according to reports, will be worth about $2.65 billion in cash and stock. The Jordanian company, which makes and markets branded and non-branded generics and injectable drugs, said the deal would make it the sixth biggest U.S. generics provider.
In a statement, the company said that it expects Roxane to achieve revenue of $725 million to $775 million in 2017, an earnings margin of about 35% over the medium term and to lift earnings per share from 2016 onwards.
Hikma are currently trading up 7.79% this morning at 2,243 per share.
Zurich Insurance confirms bid for RSA
Zurich Insurance (VTX:ZRN) has confirmed that it is considering a bid for UK-based insurance company RSA Insurance.
RSA (LON:RSA) is the owner of the More Than brand and has a market capitalisation of 4.4 billion pounds, as well as strong market positions in Scandinavia, in Canada, and a large UK commercial franchise in Latin America.
The Swiss firm said: “Zurich notes the recent market speculation in relation to RSA Insurance Group and confirms that the company is evaluating a potential offer.”
There is “no assurance that any offer will be made”, Zurich added.
The Financial Times said Zurich was considering a bid valuing RSA at 5.5 billion pounds, or 550 pence a share. Barclays analysts said Zurich had around $3 billion in surplus cash and could take on debt of up to $5 billion.
Shares in RSA were up 15 percent at 503.50 pence at 1139 GMT. Zurich shares were down 2.1 percent.